Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05647798 · ClinicalTrials.gov registry record · NA
Intrapartum Glycemic Control in GDMA2
A NA study, sponsored by Inova Health Care Services.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05647798 is a NA study that was terminated before completion, run by Inova Health Care Services. The registered enrollment target is 2 participants.
The verdict
NCT05647798, a NA study, was terminated before completion, sponsored by Inova Health Care Services.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a randomized, parallel, controlled, non-inferiority trial to assess the impact of a tight versus a more liberalized intrapartum glycemic control in gestational diabetic mothers on neonatal glycemia. National guidelines for the management of intrapartum glucose in women with GDM are lacking. This is likely due to the scarcity of high-quality data on the topic.
Interventions
- OTHER Blood sugar check every 2 hours
- OTHER Blood sugar check every 4 hours
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-05-22 |
| Est. Completion | 2024-05-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05647798
The ClinicalTrials.gov registry entry for NCT05647798 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood sugar check every 2 hours is the first listed.
NCT05647798 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05647798 about?
NCT05647798 is a clinical study titled "Intrapartum Glycemic Control in GDMA2". This is a randomized, parallel, controlled, non-inferiority trial to assess the impact of a tight versus a more liberalized intrapartum glycemic control in gestational diabetic mothers on neonatal glycemia. National guidelines for the management of intrapartum glucose in women with GDM are lacking. ...
What is the current status of trial NCT05647798?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2023-05-22. Estimated completion is 2024-05-15.
What interventions are being tested in trial NCT05647798?
The interventions under investigation include: Blood sugar check every 2 hours (OTHER), Blood sugar check every 4 hours (OTHER).
Who is sponsoring clinical trial NCT05647798?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.